Xenotransplantation: Public health risks - Patient vs. society in an emerging field

Current Topics in Microbiology and Immunology

Volumn 278, Issue , 2003, Pages 23-45

  Chapman, L E ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOSAFETY; ENDEMIC DISEASE; HEALTH HAZARD; INFECTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; REVIEW; XENOTRANSPLANTATION; ZOONOSIS;

ANIMALIA;

EID: 0041663628     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-55541-1_2     Document Type: Review

References (88)

1. Achtman M, Zurth K, Morelli G, Torrea G, Guiyoule A, Carniel E (1999) Yersinia pestis, the cause of plague, is a recently emerged clone of Yersinia pseudotuberculosis. Proceedings of the National Academy of Sciences of the United States of America 96:14043-8
2. Allan JS, Broussard SR, Michaels MG, Starzl TE, Leighton KL, Whitehead EM, Comuzzie AG, Lanford RE, Leland MM, Switzer WM, Heneine W (1998) Amplification of simian retroviral sequences from human recipients of baboon liver transplants. AIDS Research & Human Retroviruses 14:821-4
3. Aluwihare A.P.R (1999) New problems beget new solutions. Bull of the WHO 77:64-5
4. Armstrong JA, Porterfield JS, De Madrid AT (1971) C-type virus particles in pig kidney cell lines. J. Gen Virol. 10:195-8
5. Auchincloss Jr. H (1988) Xenogeneic Transplantation: A review. Transplantation 46:1-20
6. Bach FH, Fishman JA, Daniels N, et al (1998) Uncertainty in xenotransplantation: individual benefit versus collective risk. Nat Med 4:141-44
7. Belay ED (1999) Transmissible spongiform encephalopathies in humans. Annual Review of Microbiology 53:283-314
8. Brown EG (2000) Influenza virus genetics. Biomedicine & Pharmacotherapy. 54:196-209
9. Burney MI, Ghafoor A, Saleen M, Webb PA, Casals J (1980) Nosocomial outbreak of viral hemorrhagiv fever caused by Crimean Hemorrhagiv Fever-congo virus in Pakistan, January 1976. Am J Trop Med Hyg 29:941-7
10. CDC (1998) Fatal Cercopithecine herpesvirus 1 (B virus) infection following a mucocutaneous exposure and interim recommendations for worker protection. MMWR - Morbidity & Mortality Weekly Report 47:1073-6
11. Chair's draft report of the June 3-4, 1999 meeting of the Xenotransplantation Subcommittee of the Biological Response Modifyers Advisory Committee to the U.S. Food and Drug Administration. Accessible on Internet at http://www.fda.gov/ohrms/dockets/ac/cber99.htm#Biological
12. Chapman LE and Fishman JA (1997) Xenotransplantation and Infectious Diseases. In: Xenotransplantation: The Transplantation of Organs and Tissues Between Species, Edition 2. Edited by Cooper D.K.C., Kemp E., Platt J.L., White D.J. Springer-Verlag Berlin Heidelberg New York. pp 736-48
13. Chapman LE, B Ellis PhD, FT Koster MD, M Sotir MPH, T.G. Ksiazak, D.V.M., PhD, G Mertz MD, PE Rollin MD, KF Baum MD, AT Pavia MD, JC Christenson MD, PJ Rubin MD, HM Jolson MD, RE Behrman MD, AS Khan MD, LJ Wilson Bell MD, GL Simpson MD, M Carroll MD, J Hawk, RC Holman MS, CJ Peters MD, and the Ribavirin Study Group (2002) Discriminators between hantavirus-infected and hantavirus-negative persons enrolled in an open label trial of intravenous ribavirin for presumptive hantavirus pulmonary syndrome. Clinical Infectious Diseases In press, June 2001, anticipated release January 2001
14. Chapman LE, Folks TM, Salomon DR, Patterson AP, Eggerman TL, Noguichi PD (1995) Xenotransplantation and Xenogeneic Infections. New England Journal of Medicine 333:1498-1501
15. Chari RS, Collins BH, Magee JC, DiMaio JM, Kirk AD, Harland RC, McCann RL Platt JL, and Meyers WC (1994) Brief report: treatment of hepatic failure with ex vivo pig-liver perfusion followed by liver transplantation. New England Journal of Medicine 331:234-7
16. Council of Europe (1997) Recommendation on xenotransplantation, September 1997 (Internet: «htt//www.cm.coe.int/ta/rec/1997/97r15.html»)
17. Daar AS (1999) Xenotransplantation: informed consent/contract and patient surveillance. Biomedical Ethics 4:87-91
18. Dapolito G, Auchincloss H, Jr (2000) Report of the Food and Drug Administration Subcommittee on Xenotransplantation: meeting of 13 January 2000, Center for Biologics Evaluation and Research. Xenotransplantation 7:75-9
19. Deinhardt F (1980) Biology of primate retroviruses. In: Klein G, ed. Viral oncology. New York: Raven Press, 357-98
20. Donnelley S (1999) The Moral Landscape of Xenotransplantation. Presented at Cold Spring Harbor, New York on May 12, 1999 and University College, Oxford University, United Kingdom on September 17, 1999
21. Eastlund T (1995) Infectious disease transmission through cel, tissue, and organ transplantation: reducing the risk through donor selection. Cell Transplant 4:455-77
22. Eberhardt MS, Ingram DD, Makuc DM, et al (2001) Urban and Rural Health Chartbook. Health, United States, 2001. Hyatesville, Maryland: National Center for Health Statistics
23. Fink JS, Schumacher JM, Ellias SL, Palmer P, Saint-Hilaire M, Shannon K, Penn R, Starr P, VanHorne C, Knott HS, Dempsey PK, Fischman AJ, Raineri R, Manhart C, Dinsmore J, Isacson O (2000) Porcine xenografts in Parkinson's disease and Huntington's disease patients: preliminary results. Cell. Transplant. 9:273-8
24. Fischer JS (2000) Five little piggies going to market. Will clones be a source of organs for humans? US News & World Report 128:51
25. Fishman JA (1994) Miniature swine as organ donors for man: strategic for prevention of xenotransplant-associated infections. Xenotransplantation 1:27-57
26. Formenty P, Hatz C, LeGuenno B, Stoll A, Rogenmoser P, Widner A (1999) Human infection due to Ebola Virus, subtype Cote d'Ivoire: clinical and biologic presentation. Journal of Infectious Diseases 179:S48-53
27. Gerstenkorn C, Jackson G, Di Franco F, Thomusch O, Talbot D (2001) Outcome of PTLD in renal and liver allograft recipients. Transplantation Proceedings 33:2469-72
28. Gorbach SL (2001) Antimicrobial use in animal feed-time to stop. New England Journal of Medicine 345:1202-3
29. Groth CG, Korsgren O, Tibell A, Tollemar J, Moller E, Bolinder J, Ostman J, Reinholt FP, Hellerstrom C, and Andersson A (1994) Transplantation of porcine fetal pancreas to diabetic patients. Lancet 344:1402-4
30. Hahn BH, Shaw GM, De Cock KM, Sharp PM (2000) AIDS as a zoonosis: Scientific and Public health Implications. Science 287:607-14
31. Health Canada (1999) Proposed Canadian standard for xenotransplantation. The Expert Working Group on Xenotransplantation. July 1999 (Available on the Internet: www.hc-sc.gc.ca/hpb-dgps/therapeut/zfiles/english/btox/standards/xeno_std_e. html)
32. Health Council of the Netherlands (1998) Committee on Xenotransplantation. xenotransplantation. Rijswijk, The Netherlands: Health Council of The Netherlands, 1998; publication no. 1998/01E
33. Heneine W, Switzer WM, Sandstrom P, Brown J, Vedipuri S, Shable CA, Khan AS, Lerche NW, Schweizer M, Neumann-Haefelin D, Chapman LE, Folks TM (1998) Identification of a human population infected with simian foamy viruses. Nature Medicine 4:403-7
34. Heneine W, Switzer WM, Soucie JM, Evatt BL, Shanmugam V, Rosales GV, Matthews A, Sandstrom P, Folks TM (2001) Evidence of porcine endogenous retroviruses in porcine factor VIII and evaluation of transmission to recipients with hemophilia. Journal of Infectious Diseases 183:648-52
35. Heneine W, Tibell A, Switzer WM, Sandstrom P, Rosales GV, Matthews A, Korsgren O, Chapman LE, Folks TM, Groth CG (1998) No evidence of infection with the porcine endogenous retrovirus in human recipients of porcine islet cell xenografts. Lancet 352:695-9
36. Hirsch VM, Olmsted RA, Murphey-Corb M, Purcell RH, Johnson PR (1989) An African primate lentivirus (SIVsm) closely related to HIV-2. Nature 339:389-92
37. Hoberg EP, Alkire NL, de Queiroz A, Jones A (2001) Out of Africa: origins of the Taenia tapeworms in humans. Proceedings of the Royal Society of London - Series B: Biological Sciences 268:781-7
38. Hussain AI, Shanmugam V, Switzer WM, Tsang SX, Fadly A, Thea D, Helfand R, Bellini WJ, Folks TM, Heneine W (2001) Lack of evidence of endogenous avian leukosis virus and endogenous avian retrovirus transmission to measles, mumps, and rubella vaccine recipients. Emerging Infectious Diseases 7:66-72
39. Imaizumi T, Lankford KL, Burton WV, Fodor WL, Kocsis JD (2000) Xenotransplantation of pig olfactory ensheathing cells promotes axonal regeneration in rat spinal cord. Nature Biotechnology 18:949-53
40. Institute of Medicine (1996) Xenotransplantation: Science, Ethics, and Public Policy. National Academy Press, Washington, D.C
41. Johnson JA, Heneine W (2001) Characterization of endogenous avian leukosis viruses in chicken embryonic fibroblast substrates used in production of measles and mumps vaccines. Journal of Virology 75:3605-12
42. Khabbaz RF, Heneine W, George JR, Parekh B, Rowe T, Woods T, Switzer WM, McClure HM, Murphey-Corb M, Folks TM (1994) Brief report: infection of a laboratory worker with simian immunodeficiency virus. New England Journal of Medicine 330:172-7
43. Kind A, Colman A (1999) Therapeutic cloning: needs and prospects. Seminars in Cell & Developmental Biology 10:279-86
44. Klimov AI, Rocha E, Hayden FG, et al (1995) Prolonged shedding of amantadine-resistant influenza A viruses by immunodeficient patients: detection by polymerase chain reaction-restriction analysis. J Infect Dis 172:1352-5
45. LeBlanc MH, Boudriau S, Doyle D, Gagnon A, Beaudoin D, Coulombe D, Gleeton O, Kingma JG Jr., Boutet M (1998) Epstein-Barr virus mediated graft rejection in heart transplant patients: implication of the cardiac cytoskeleton. Transplantation Proceedings 30:918-24
46. Martini GA (1969) Marburg agent disease: in man. Trans R Soc Trop Med Hug 63:295-302
47. Michaels MG, Jenkins FJ, St George K, Nalesnik MA, Starzl TE, Rinaldo CR Jr (2001) Detection of infectious baboon cytomegalovirus after baboon-to-human liver xenotransplantation. Journal of Virology 75:2825-8
48. Michaels MG, Simmons RL (1994) Xenotransplant-associated zoonoses: strategies for prevention. Transplantation 57:1-7
49. Murphy FA (1996) The public health risk of animal organ and tissue transplantation into humans. Science 273:746-7
50. Nyberg SL, Hibbs JR, Hardin JA, Germer JJ, Persing DH (1999) Transfer of porcine endogenous retrovirus across hollow fiber membranes: significance to a bioartificial liver. Transplantation 67:1251-5
51. th International Workshop of Retroviral Pathogenesis; October 30, 2000; Annapolis, Maryland
52. Oxford JS (2000) Influenza A pandemic of the 20th century with special reference to 1918: virology, pathology and epidemiology. Reviews in Medical Virology 10:119-33
53. Paradis K, Langford G, Long Z, Heneine W, Sandstrom P, Switzer WM, Chapman LE, Lockey C, Onions D, the Xen 111 Study Group, Otto E (1999) Search for cross species transmission of porcine endogenous retrovirus in patients treated with living pig tissue. Science 285:1236-41
54. Parashar UD, Sunn LM, Ong F, Mounts AW, Arif MT, Ksiazek TG, Kamaluddin MA, Mustafa AN, Kaur H, Ding LM, Othman G, Radzi HM, Kitsutani PT, Stockton PC, Arokiasamy J, Gary HE Jr, Anderson LJ (2000) Case-control study of risk factors for human infection with a new zoonotic paramyxovirus, Nipah virus, during a 1998-1999 outbreak of severe encephalitis in Malaysia. Journal of Infectious Diseases 181:1755-9
55. Patience C, Patton GS, Takeuchi Y, Weiss RA, McClure MO, Rydberg L, Breimer ME (1998) No evidence of pig DNA or retroviral infection in patients with short-term extracorporeal connection to pig kidneys. Lancet 352:699-701
56. Patience C, Takeuchi Y, Weiss RA (1997) Infection of human cells by an endogenous retrovirus of pigs. Nature Medicine 3:282-6
57. Pitkin Z, Mullon C (1999) Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system. Artif Organs 23:829-33
58. Qari SH, Magre S, Garcia-Lerma JG, Hussain AI, Takeuchi Y, Patience C, Weiss RA, Heneine W (2001) Susceptibility of the porcine endogenous retrovirus to reverse transcriptase and protease inhibitors. Journal of Virology 75:1048-53
59. Reemtsma K (1969) Renal heterotransplantation from nonhuman primates to man. Ann NY Acad Sci 162:412
60. Rocha E, Cox NJ, Black RA, et al (1991) Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child. J Virol 65:2340-50
61. Schumacher JM, Elias SA, Palmer EP, et al (2000) Transplantation of embryonic porcine mesencephalic tissue in patients with PD. Neurology 54:1042-50
62. Simonds RH (1993) HIV transmission by organ and tissue transplantation. AIDS 7:Suppl 2:S35-S38
63. Stoye JP, Coffin JM (1995) The dangers of xenotransplantation. Nature Medicine 11:1100
64. Stoye JP, Le Tissier P, Takeuchi Y, Patience C, Weiss RA (1998) Endogenous retroviruses: a potential problem for xenotransplantation? Annals of the New York Academy of Sciences 862:67-74
65. Stoye JP (1997) Xenotransplantation. Proviruses pose potential problems. Nature 386:126-7
66. Stoye JP (1998) No clear answers on safety of pigs as tissue donor source. Lancet 352:666-7
67. Stoye JP (1999) The pathogenic potential of endogenous retroviruses: a skeptical view. Trends in Microbiology 7:430
68. Strandstrom H, Vejalainen P, Moenning V, Hunsmann G, Schwartz H, Schafer W (1974) C-type particles produced by a permanent cell line from a leukemic pig. 1. Origin and properties of the host cells and some evidence of the occurrence of C-type-like particles. Virology 57:175-8
69. Strickler HD, Rosenberg PS, Devesa SS, Hertel J, Fraumeni JF Jr., Goedert JJ (1998) Contamination of poliovirus vaccines with simian virus 40 (1953-1963) and subsequent cancer rates. JAMA 279:292-5
70. Subbarao K, Katz J (2000) Avian influenza viruses infecting humans. Cellular & Molecular Life Science 57:1770-84
71. Subcommission of Xenotransplantation of the Permanent Commission of Transplants of the Interterritorial Council of the National Health System (1998) Xenotransplantation: recommendations for the regulation of these activities in Spain. Available in Spanish or English translation from: Organizacion Nacional de Transplantes, C/ Sinesio Delgado, 8, 28029 Madrid, Tel: (44) 91 314 24 06; Fax: (44) 91 314 29 69; E-mail: bmiranda@msc.es
72. Suleiman MN, Muscat-Baron JM, Harries JR, et al (1980) Congo/Crimean haemorrhagic fever in Dubai:an outbreak at the Rashid Hospital. Lancet 2:939-41
73. Swanepoel R, Shepherd AH, Leman PA, et al (1987) Epidemiologic and clinical features of Crimean-Congo hemorrhagiv fever in southern Africa. Am J Trop Med Hyg 36:120-32
74. Swedish Committee on Xenotransplantation (1999) From one species to anothertransplantation from animals to humans. A report by the Swedish Committee on Xenotransplantation, Stockholm. Swedish Government Official Report No. 1999:120. Ministry of health and Social Affairs. The complete report in Swedish or a short version (Summary and Statutory Proposals) in English are available upon request from: Stefan Reimer, Secretary, The Swedish committee on xenotransplantation, P.O. Box 187, S-201 21 MALMO, Sweden. E-mail: stefan.reimer@hsb.dom.se
75. Todaro GJ, Beneveniste RE, Lieber MM, Sherr CJ (1974) Characterization of a type C virus released from the porcine cell line PK (15). Virology 58:65-74
76. Transplantation Society of Australia and New Zealand, Inc (1998) Xenotransplantation: a report to the Research Committee (Public Health and Medical), the National health and medical Research council, from an Ad Hoc Working Party, August 1998. Revised December 1998 (Internet:«http://www.racp.edu.au/tsanz/xenomain.htm»)
77. Tsang SX, Switzer WM, Shanmugam V, Johnson HA, Goldsmith C, Wright A, Fadly A, Thea D, Jaffe H, Folks TM, Heneine W (1999) Evidence of avian leukosis virus subgroup E and endogenous avian virus in measles and mumps vaccines derived from chicken cells: investigation of transmission to vaccine recipients. Journal of Virology 73:5843-51
78. U.S. Public Health Service (2001) PHS Guideline on Infectious Disease Issues In Xenotransplantation. MMWR Recommendations and Reports. 50 (RR-15):1-46
79. United Kingdom Department of Health (1997) The Government Response to "Animal Tissues into Humans." The report of the Advisory Group on the Ethics of Xenotransplantation. The Stationary Office, London, January 1997 (Further information is available on the United Kingdom Xenotransplantation Interim Regulatory Authority (UKXIRA) website: «http://www.doh.gov.uk/ukxira.htm»)
80. United Network for Organ Sharing (1997). Data highlights from the 1997 Annual Report: The U.S. Scientific Registry of Transplant Recipients and the Organ Procurement and Transplantation Network - Transplant data: 1988-1996. U.S. Department of Health and Human Services, Rockville, MD
81. Van der Laan LJW, Lockey C, Griffeth BC, et al (2000) Infection by porcine endogenous retrovirus after islet xenotransplantation in SCID mice. Nature 407:90-4
82. Weiss RA (2001) The Leeuwenhoek Lecture 2001. Animal origins of human infectious disease. Philosophical Transactions of the Royal Society of London - Series B: Biological Sciences. 356:957-77
83. Wells DL, Hopfensperger DJ, Arden NH, Harmon MW, Davis JP, Tipple MA, Schonberger LB (1991) Swine influenza virus infections. Transmission from ill pigs to humans at a Wisconsin agricultural fair and subsequent probable person-to-person transmission. JAMA 265:478-81
84. WHO (1978) Ebola haemorrhagic fever in Zaire, 1976. Bull World Health Organ 56:271-93
85. Wilson CA, Wong S, Muller J, et. al (1998) Type C retrovirus released from porcine primary peripheral blood mononuclear cells infects human cells. J Virol 72:3082-3087
86. Woolhouse MEJ, Taylor LH, Haydon DT (2000) Population Biology of Multihost Pathogens. Science 292:1109-1112
87. World Health Organization (1998) Xenotransplantation: guidance on infectious disease prevention and management. World health Organization, Geneva, Switzerland, November 1998 (document WHO/EMC/ZOO/98.1; available from Division of Emerging and Other Communicable Diseases Surveillance and Control, World Health Organization, 1211 Geneva 27, Switzerland) (Internet: «http://www.who.int/emc-documents/zoonoses/whoemczoo981c.html»)
88. Zhang Z, Bedard E, Luo Y, Wang H, Deng S, Kelvin D, Zhong R (2000) Animal models in xenotransplantation. Exp. Opin. Invest. Drugs 9:2051-68